Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?

Commentary to: Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan Justin M. Drake, Joshua R. Danke and Michael Henry

Saved in:
Bibliographic Details
Published in:Cancer biology & therapy 2010-04, Vol.9 (8), p.615-617
Main Authors: Roh, Meejeon, Abdulkadir, Sarki A.
Format: Article
Language:English
Subjects:
Animals
Atrasentan
Binding
Biology
Bioscience
Bone Neoplasms - drug therapy
Bone Neoplasms - secondary
Calcium
Cancer
Cell
Cycle
Disease Models, Animal
Endothelin Receptor Antagonists
Humans
Landes
Male
Mice
Molecular Targeted Therapy - methods
Organogenesis
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Proteins
Pyrrolidines - pharmacology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Commentary to: Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan Justin M. Drake, Joshua R. Danke and Michael Henry
ISSN:1538-4047
1555-8576
DOI:10.4161/cbt.9.8.11309